Harrison, D.E., Strong, R., Reifsnyder, P., Kumar, N., Fernandez, E., Flurkey, K., Javors, M.A., Lopez-Cruzan, M., Macchiarini, F., Nelson, J.F., Markewych, A., Bitto, A., Sindler, A.L., Cortopassi, G., Kavanagh, K., Leng, L., Bucala, R., Rosenthal, N., Salmon, A., Stearns, T.M., Bogue, M. and Miller, R.A. (2021), 17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex. Aging Cell, 20: e13328. https://doi.org/10.1111/acel.13328
Maric T, Bazhin A, Khodakivskyi P, Mikhaylov G, Solodnikova E, Yevtodiyenko A, Giordano Attianese GMP, Coukos G, Irving M, Joffraud M, Cantó C, Goun E. A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism. Biosens Bioelectron. 2023 Jan 15;220:114826. doi: 10.1016/j.bios.2022.114826. Epub 2022 Oct 29. PMID: 36371959.
Berge, K.G., Canner, P.L. & Coronary Drug Project Research Group. Coronary drug project: Experience with niacin. Eur J Clin Pharmacol 40, S49–S51 (1991). https://doi.org/10.1007/BF01409409
Ying, H., Gao, L., Liao, N. et al. Association between niacin and mortality among patients with cancer in the NHANES retrospective cohort. BMC Cancer 22, 1173 (2022). https://doi.org/10.1186/s12885-022-10265-4
Pirinen et al. (2020). Niacin Cures Systemic NAD Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell Metab. 2020 Jun 2;31(6):1078-1090.e5. doi: 10.1016/j.cmet.2020.04.008. Epub 2020 May 7.
Irie et al. (2020). Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men. Endocr J. 2020 Feb 28;67(2):153-160. doi: 10.1507/endocrj.EJ19-0313. Epub 2019 Nov 2.
Trammell et al. (2016). Nicotinamide Riboside Is Uniquely and Orally Bioavailable in Mice and Humans. Nat Commun. 2016 Oct 10;7:12948. doi: 10.1038/ncomms12948.
Airhart et al. (2017). An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD levels in healthy volunteers. PLoS One. 2017 Dec 6;12(12):e0186459. doi: 10.1371/journal.pone.0186459.
Martens et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD in healthy middle-aged and older adults. Nature Communications volume 9, Article number: 1286.
Dollerup et al. (2018). A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin-Sensitivity, and Lipid-Mobilizing Effects. Am J Clin Nutr. 2018 Aug 1;108(2):343-353. doi: 10.1093/ajcn/nqy132.
Dolopikou et al. (2020). Acute Nicotinamide Riboside Supplementation Improves Redox Homeostasis and Exercise Performance in Old Individuals: A Double-Blind Cross-Over Study. Eur J Nutr. 2020 Mar;59(2):505-515. doi: 10.1007/s00394-019-01919-4. Epub 2019 Feb 6.
Elhassan et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep. 2019 Aug 13; 28(7): 1717–1728.e6.
Conze et al. (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Sci Rep. 2019 Jul 5;9(1):9772. doi: 10.1038/s41598-019-46120-z.
Remie et al. (2020). Nicotinamide Riboside Supplementation Alters Body Composition and Skeletal Muscle Acetylcarnitine Concentrations in Healthy Obese Humans. Am J Clin Nutr. 2020 Apr 22; nqaa072. doi: 10.1093/ajcn/nqaa072.
Dollerup et al. (2020). Nicotinamide Riboside Does Not Alter Mitochondrial Respirat